Digital Content 
NEWS #PharmaBuzz
21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721000805/en/Cycle-Pharmaceuticals-Selects-LeMed-Specialty-Pharmacy-as-Exclusive-U.S.-Specialty-Pharmacy-Distribution-and-Services-Partner-for-HARLIKU-nitisinone-Tablets-the-First-and-only-FDA-approved-Treatment-for-Adult-Patients-with-Alkaptonuria-AKU
21 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cycle-pharmaceuticals-selects-lemed-specialty-pharmacy-as-exclusive-us-specialty-pharmacy-distribution-and-services-partner-for-harliku-nitisinone-tablets-the-first-and-only-fda-approved-treatment-for-reducing-urinary-homoge-302506082.html
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250716344652/en/Cycle-Pharmaceuticals-launches-HARLIKU-nitisinone-Tablets-the-first-FDA-approved-treatment-for-use-in-Alkaptonuria-AKU
20 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250611798305/en/Cycle-Pharmaceuticals-HARLIKU-nitisinone-Tablets-Receive-First-FDA-Approval-as-Treatment-for-Alkaptonuria-AKU
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879121/0/en/Eton-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results.html
02 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/02/2822744/0/en/Eton-Pharmaceuticals-Announces-Commercial-Availability-of-Ultra-Rare-Disease-Product-Nitisinone-Capsules.html
Share 